+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sleeping Aids - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140279
The global market for Sleeping Aids was estimated at US$90.2 Billion in 2023 and is projected to reach US$129.4 Billion by 2030, growing at a CAGR of 5.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Sleeping Aids Market - Key Trends and Drivers Summarized

Why Are Sleeping Aids Becoming Essential for Addressing Sleep Disorders?

Sleeping aids are becoming essential for addressing sleep disorders such as insomnia, sleep apnea, and restless leg syndrome due to their ability to improve sleep quality, duration, and overall health. The growing prevalence of sleep disorders, driven by factors such as stress, anxiety, lifestyle changes, and aging, is increasing the demand for effective sleep solutions. Sleeping aids, including over-the-counter (OTC) sleep medications, supplements, wearable sleep trackers, smart mattresses, and digital sleep solutions, offer a wide range of options for individuals seeking to improve their sleep patterns. The rising awareness about the impact of sleep quality on physical, mental, and emotional well-being is further driving the adoption of sleeping aids among consumers, healthcare providers, and wellness centers.

How Are Technological Advancements Transforming Sleeping Aids?

Technological advancements are transforming sleeping aids by integrating data-driven, personalized, and holistic sleep health solutions that go beyond traditional sleep medications. The development of wearable sleep trackers, smart mattresses, and digital sleep apps is enabling real-time monitoring of sleep patterns, heart rate, and breathing, providing actionable insights for improving sleep hygiene. Innovations in AI-driven algorithms, cognitive behavioral therapy for insomnia (CBT-I), and biofeedback mechanisms are enhancing the efficacy of digital sleep solutions, making them more accessible and user-friendly. Additionally, the emergence of natural, herbal, and non-pharmacological sleep aids, such as melatonin, valerian root, and CBD-infused products, is catering to the growing demand for safe, effective, and non-addictive sleep solutions. These advancements are addressing the limitations of traditional sleep aids and driving the shift toward integrated and multidimensional sleep health management.

Which Market Segments Are Leading the Adoption of Sleeping Aids?

Product types include sleep medications, sleep apnea devices, sleep laboratories, and sleep wellness products, with sleep medications and sleep apnea devices leading the market due to their high demand and accessibility. Sleep disorders include insomnia, sleep apnea, restless leg syndrome, and narcolepsy, with insomnia being the largest segment due to its high prevalence and impact on daily functioning. Distribution channels include pharmacies, e-commerce platforms, specialty stores, and hospitals, with pharmacies and e-commerce platforms being the primary distribution channels due to their convenience and wide reach. Geographically, North America and Europe are the largest markets for sleeping aids due to high awareness of sleep health, advanced healthcare infrastructure, and growing demand for OTC sleep solutions, while Asia-Pacific is emerging as a high-growth region driven by increasing urbanization, stress-related sleep issues, and rising disposable incomes.

What Are the Key Drivers of Growth in the Sleeping Aids Market?

The growth in the sleeping aids market is driven by several factors, including the rising prevalence of sleep disorders, increasing awareness about the impact of sleep quality on overall health, and technological advancements in wearable sleep trackers, smart mattresses, and digital sleep solutions. The development of natural, herbal, and non-pharmacological sleep aids is driving market adoption among health-conscious consumers, wellness centers, and healthcare providers. The focus on enhancing efficacy, safety, and patient experience in sleep health management is expanding the market reach among diverse patient populations, including geriatrics, pediatrics, and shift workers. The growing use of sleeping aids in cognitive behavioral therapy, holistic wellness programs, and integrated health solutions, coupled with the demand for outcome-based, value-driven, and personalized sleep health management, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for novel sleep aids, clinical trials, and consumer education and the rising collaborations between sleep specialists, psychiatrists, and sleep aid manufacturers are further supporting market expansion.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Sleep Apnea Devices segment, which is expected to reach US$36.9 Billion by 2030 with a CAGR of a 6.0%. The Medication segment is also set to grow at 4.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $23.9 Billion in 2023, and China, forecasted to grow at an impressive 8.1% CAGR to reach $29.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Sleeping Aids Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Sleeping Aids Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Sleeping Aids Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • Abecca Healthcare
  • Becton, Dickinson and Company
  • Betterlifehealthcare Ltd.
  • Cadwell Industries, Inc.
  • Compumedics Ltd.
  • GlaxoSmithKline, Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips NV
  • Lifeline Corporation Pte Ltd
  • Merck & Co., Inc.
  • Natus Medical, Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Sleeping Aids - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Sleep Disorders, Insomnia, and Stress-Related Sleep Issues Drives Demand for Sleeping Aids
  • Growing Awareness About the Impact of Sleep Quality on Overall Health Expands Addressable Market Opportunity
  • Advancements in Drug-Free, Natural, and Herbal Sleeping Aids Propel Market Adoption
  • Increasing Use of Wearable Sleep Trackers, Smart Mattresses, and Digital Sleep Solutions Reinforces Market Competitiveness
  • Rising Preference for Over-the-Counter (OTC) Sleep Medications and Supplements Generates New Growth Opportunities
  • Focus on Enhancing Efficacy, Safety, and Patient Experience in Sleeping Aids Drives Innovation
  • Growing Demand for Non-Pharmacological, Cognitive Behavioral Therapy (CBT) for Insomnia Sustains Market Growth
  • Development of Personalized, AI-Driven, and Data-Backed Sleep Solutions Expands Market Reach
  • Focus on Addressing Sleep Disorders in High-Risk Groups, Such as Shift Workers and Pregnant Women, Drives Market Demand
  • Emergence of Melatonin-Based, Valerian Root-Based, and CBD-Infused Sleeping Aids Spurs Market Adoption
  • Shift Towards Integrated, Holistic, and Multidimensional Sleep Health Management Solutions Supports Market Growth
  • Rising Adoption of Sleep Aids in Geriatric, Pediatric, and Adolescent Populations Creates New Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Sleeping Aids Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Sleeping Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Sleeping Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Sleeping Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Sleep Apnea Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Sleep Apnea Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Sleep Apnea Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Mattresses & Pillows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Mattresses & Pillows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Mattresses & Pillows by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Sleep Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Sleep Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Sleep Laboratory Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 18: USA Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: USA 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: Canada Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: Canada 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
JAPAN
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: Japan Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: Japan 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
CHINA
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: China Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: China 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
EUROPE
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Sleeping Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Sleeping Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Europe 16-Year Perspective for Sleeping Aids by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Europe 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
FRANCE
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: France Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: France 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
GERMANY
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Germany Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Germany 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Italy Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Italy 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: UK Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: UK 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
SPAIN
  • Table 47: Spain Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Spain Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Spain 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
RUSSIA
  • Table 50: Russia Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Russia Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Russia 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 53: Rest of Europe Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Rest of Europe Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Rest of Europe 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Sleeping Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Sleeping Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Sleeping Aids by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Sleeping Aids by Segment - Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Asia-Pacific 16-Year Perspective for Sleeping Aids by Segment - Percentage Breakdown of Value Sales for Sleep Apnea Devices, Medication, Mattresses & Pillows and Sleep Laboratory Services for the Years 2014, 2024 & 2030
AUSTRALIA
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Sleeping Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abecca Healthcare
  • Becton, Dickinson and Company
  • Betterlifehealthcare Ltd.
  • Cadwell Industries, Inc.
  • Compumedics Ltd.
  • GlaxoSmithKline, Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips NV
  • Lifeline Corporation Pte Ltd
  • Merck & Co., Inc.
  • Natus Medical, Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.

Table Information